News
09-26-2008, 07:21 AM
Three enzymes called phosphatases that shut down a molecule called SRC-3 (steroid receptor coactivator 3) could provide a new pathway for fighting cancer, particularly tumors of the breast and prostate, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Molecular Cell. "This kind of information provides a target for the production of drugs against cancer," said Dr.
More... (http://www.medicalnewstoday.com/articles/123191.php)
More... (http://www.medicalnewstoday.com/articles/123191.php)